These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2843883)

  • 21. Overview: occluded ions and Na, K-ATPase.
    Forbush B
    Prog Clin Biol Res; 1988; 268A():229-48. PubMed ID: 2843866
    [No Abstract]   [Full Text] [Related]  

  • 22. Excimer formation in pyrenemaleimide-labeled sarcoplasmic reticulum ATPase.
    Lüdi H; Hasselbach W
    Biophys J; 1987 Mar; 51(3):513-5. PubMed ID: 2952178
    [No Abstract]   [Full Text] [Related]  

  • 23. Eosin as a fluorescence probe for measurement of conformational states of Na+,K+-ATPase.
    Skou JC; Esmann M
    Methods Enzymol; 1988; 156():278-81. PubMed ID: 2452960
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of mono- and bifunctional group-specific reagents in the study of the renal Na+ -K+-ATPase.
    de Pont JJ; Schoot BM; Bonting SL
    Int J Biochem; 1980; 12(1-2):307-13. PubMed ID: 6249663
    [No Abstract]   [Full Text] [Related]  

  • 25. Diversity of the E2P phosphoforms of Na,K-ATPase.
    Fedosova NU; Cornelius F; Forbush B; Klodos I
    Ann N Y Acad Sci; 1997 Nov; 834():386-9. PubMed ID: 9432913
    [No Abstract]   [Full Text] [Related]  

  • 26. Electron spin resonance investigations of Na+,K+-ATPase.
    Esmann M
    Methods Enzymol; 1988; 156():371-6. PubMed ID: 2835620
    [No Abstract]   [Full Text] [Related]  

  • 27. Coupled assay of Na+,K+-ATPase activity.
    Nørby JG
    Methods Enzymol; 1988; 156():116-9. PubMed ID: 2835597
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative analysis of oxonol V fluorescence in submitochondrial particles.
    Freedman JC; Novak TS; Penefsky HS; Stein WD
    Ann N Y Acad Sci; 1992 Nov; 671():493-6. PubMed ID: 1337685
    [No Abstract]   [Full Text] [Related]  

  • 29. Conformational relationships between distinct regions in the myosin molecule.
    Schaub MC; Watterson JG; Loth K; Waser PG
    Biochimie; 1979; 61(7):791-801. PubMed ID: 229917
    [No Abstract]   [Full Text] [Related]  

  • 30. N-(3-pyrene)maleimide: a long lifetime fluorescent sulfhydryl reagent.
    Weltman JK; Szaro RP; Frackelton AR; Dowben RM; Bunting JR; Cathou BE
    J Biol Chem; 1973 May; 248(9):3173-7. PubMed ID: 4121698
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluorescent tracer method for protein SH groups. II.
    Yamamoto K; Okamoto Y; Sekine T
    Anal Biochem; 1978 Jan; 84(1):313-8. PubMed ID: 626373
    [No Abstract]   [Full Text] [Related]  

  • 32. Overview: the phosphointermediates of Na,K-ATPase.
    Nørby JG; Klodos I
    Prog Clin Biol Res; 1988; 268A():249-70. PubMed ID: 2843867
    [No Abstract]   [Full Text] [Related]  

  • 33. Structural changes in Na, K-ATPase estimated by intrinsic and extrinsic fluorescence probes.
    Taniguchi K; Suzuki K; Sasaki T; Tosa H; Shinoguchi E
    Prog Clin Biol Res; 1988; 268A():369-76. PubMed ID: 2843883
    [No Abstract]   [Full Text] [Related]  

  • 34. Stopped-flow kinetic investigations of conformational changes of pig kidney Na+,K+-ATPase.
    Kane DJ; Fendler K; Grell E; Bamberg E; Taniguchi K; Froehlich JP; Clarke RJ
    Biochemistry; 1997 Oct; 36(43):13406-20. PubMed ID: 9341234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational change accompanying transition of ADP-sensitive phosphoenzyme to potassium-sensitive phosphoenzyme of (Na+,K+)-ATPase modified with N-[p-(2-benzimidazolyl)phenyl]maleimide.
    Taniguchi K; Suzuki K; Iida S
    J Biol Chem; 1982 Sep; 257(18):10659-67. PubMed ID: 6286667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E2P phosphoforms of Na,K-ATPase. II. Interaction of substrate and cation-binding sites in Pi phosphorylation of Na,K-ATPase.
    Cornelius F; Fedosova NU; Klodos I
    Biochemistry; 1998 Nov; 37(47):16686-96. PubMed ID: 9843437
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.